Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Subcutaneous planning from a 50 mg vial reconstituted with 3.0 mL BAC water (~16.7 mg/mL) Phase Days 12 (tolerance) Daily dose 2.5 mg once daily Units on U-100 syringe 15 units Volume 0.15 mL Phase Days 3+ (standard) Daily dose 5 mg once daily Units on U-100 syringe 30 units Volume 0.30 mL Phase Split option (BID) Daily dose 2.5 mg twice daily Units on U-100 syringe 15 units each Volume 0.15 mL each Subcutaneous doses are much smaller than oral doses because of injection volume limits and because direct subQ absorption skips the gut
These aim to complementother aspects of a weight loss regimen, including exercise and a low calorie diet
nevertheless, compounded preparations lacking antimicrobial preservatives are conventionally assigned a beyond-use date of 28 days when maintained under USP medium-risk conditions
Wolffenbuttel BHR, Wouters H, de Jong WHA, Huls G, van der Klauw MM
Rotate injection sites within the general area to prevent scar tissue accumulation
